ReviewJournal of neurochemistry2026
From Synapses to Circuits, the Role of KIBRA and the WWC Family in Adaptive Brain Function.
Review in Journal of neurochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
KIBRA (WWC1) has been a subject of scientific interest and investigation for almost two decades following its initial association with nonpathological variation in human memory performance. Work in a variety of animal models confirms that KIBRA supports memory function and demonstrates that regulation of AMPA-type glutamate receptors is a key mechanism by which KIBRA modulates neuronal function. KIBRA is a scaffolding protein at excitatory synapses, and its interactome is enriched for proteins that regulate AMPA receptor (AMPAR) trafficking and synaptic plasticity as well as neurodevelopmental disorders. Here, I provide a comprehensive discussion of known and potential mechanisms by which KIBRA and its interactome regulate adaptive brain function, encompassing AMPAR trafficking, synaptic plasticity, and experience-induced modification of circuit dynamics. Disrupted KIBRA function is implicated in a variety of cognitive disorders, and I review mechanisms by which KIBRA may contribute to neuropathology as well as recent work suggesting that KIBRA manipulation may be a target for cognitive enhancement. I expand the discussion to include recent data identifying the KIBRA homolog WWC2 as a regulator of GABA
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.